Diagnostic and Prognostic Products. In no event will any milestone, net sales or royalty payments become due or owing pursuant to Section 5.1 or 5.2 above with respect to any Allogene Licensed Product Developed or Commercialized for diagnostic or prognostic purposes.
Appears in 3 contracts
Samples: License Agreement (Allogene Therapeutics, Inc.), License Agreement (Cellectis S.A.), License Agreement (Cellectis S.A.)
Diagnostic and Prognostic Products. In no event will any milestone, net sales or royalty payments become due or owing pursuant to Section 5.1 Sections 5.3 or 5.2 5.4 above with respect to any Allogene Pfizer Licensed Product Developed or Commercialized for diagnostic or prognostic purposes.
Appears in 1 contract
Samples: Research Collaboration and License Agreement (Allogene Therapeutics, Inc.)